iShares Biotechnology ETF IBB
203.72 USD -1.67 (-0.81%)
Regular-session close
203.00 -0.72 -0.35%
After hours · Nov 19, 7:00 PM ET
203.29 Day range 208.00
159.68 52-week range 222.29
- YTD
- +20.71%
- 1 year
- +23.30%
Benzinga news
benzinga.com Oracle Launches Life Sciences AI Agents To Work On Clinical Trial Operations By bringing together insights from Oracle Life Sciences applications and supported third-party data sources, the agents are designed to help clinical trial teams identify operational issues,…
benzinga.com Biotech ETFs Brace for FDA Showdown: Two Drug Decisions Could Test Investor Sentiment XBI and IBB lagged SPY and QQQ as two FDA decisions and fresh Alzheimer's and obesity-drug data put biotech ETFs in focus.
benzinga.com Hims-Eli Lilly GLP-1 Deal Meets Summit’s FDA Gamble: Which Biotech ETFs Stand to Gain? Biotech ETFs face key FDA catalysts as Summit Therapeutics' decision and the Hims-Lilly GLP-1 deal put XLV, IBB and XBI in focus.
benzinga.com Alphabet Posts Worst Week Since 2011, Intel Suffers Record Crash as Warsh Sees 'Cracks': This Week on Wall Street Alphabet logs its worst week since 2011 and Intel its worst day ever as the AI trade cracks, while health care posts a record month against the market.
